Related Experiment Video
Updated: Jun 30, 2026
05:28
Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
Published on: December 9, 2022
Statins and sepsis: good bullet, disappearing target
Richard H Woerndle1, Daniel L Maxwell
1Pontiac Osteopathic Hospital Medical Center, MI, USA. woernd01@srmc.org
The Journal of the American Osteopathic Association
|September 23, 2008
Summary
Statins may not benefit sepsis patients throughout the entire illness. Their anti-inflammatory effects might be harmful during specific immune responses in sepsis, suggesting cautious use.
Area of Science:
- Critical care medicine
- Pharmacology
- Immunology
Background:
- Sepsis is a leading cause of death, with limited therapeutic improvements beyond early antibiotics and supportive care.
- Statins are known for anti-inflammatory and lipid-lowering properties, prompting investigation into their role in sepsis management.
Purpose of the Study:
- To review the pathophysiologic mechanisms of sepsis.
- To evaluate the pharmacologic effects of statins in the context of sepsis.
Main Methods:
- Concise review of pertinent literature on sepsis pathophysiology.
- Analysis of existing research on statin effects during different phases of sepsis.
Main Results:
- Statins' anti-inflammatory and lipid-lowering effects may not be universally beneficial during sepsis.
- Statin benefits appear limited to the periods before sepsis onset and during resolution, not during acute inflammatory phases.
Conclusions:
- Uninterrupted statin therapy throughout sepsis may be detrimental.
- Avoid continuous statin use until a patient's immune response status in sepsis is clearly understood.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...